Abdel-Kahaar, Emaad
Keller, Frieder http://orcid.org/0000-0001-9280-3334
Funding for this research was provided by:
Universität Ulm
Article History
Accepted: 21 March 2023
First Online: 3 May 2023
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL.
: Frieder Keller received a 1200 € honorarium for participating in a teaching seminar at Otsuka company. Emaad Abdel-Kahaar has no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors possess no more than the published and referenced data, and more documented material is not available.
: Not applicable.
: The first author, EAK, contributed to the review of clinical studies and the report of pharmacogenetic data. The second author, FK, contributed to the interpretation of pharmacokinetic and pharmacodynamic data and the figures. Both authors contributed to the writing of the text.